UBS AM’s Eton Pharmaceutcials ETON Stock Holding History

UBS AM’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.3K	Hold	368	–	–	﹤0.01%	3213
2026 Q1	$9.08K	Buy	+368	New	+$6.43K	﹤0.01%	3330

Other funds holding ETON

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

UBS AM's ETON Position: Q2 2026 in Review

UBS AM held its Eton Pharmaceutcials (ETON) position steady in Q2 2026 at 368 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3213.

UBS AM first reported a position in ETON in Q1 2026 and has held it in 2 quarters since. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

UBS AM held 368 shares of Eton Pharmaceutcials worth $13.3K as of Q2 2026.
UBS AM left its Eton Pharmaceutcials share count unchanged in Q2 2026.
Eton Pharmaceutcials made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3213 holding.
UBS AM first reported a position in Eton Pharmaceutcials in Q1 2026 and has held it in 2 quarters since.
165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.